development. The agent, Neoprobe’s Lymphoseek, will be the result of cooperation between researchers from two companies, Phylogeny, from Columbus, Ohio, and Neoprobe, a company based in Dublin, Ohio.http://www.healthimaginghub.com/article/1627-lymphoseek-provides-a-new-option-for-imaging-head-and-neck-cancers.html
No comments:
Post a Comment